NCT02680990

Brief Summary

This is a pilot study to evaluate the feasibility of, adherence to, and early efficacy of Band Together, a strength-training and walking program (intervention arm) vs. education on the benefits of exercise (control arm) in patients with aggressive gastrointestinal (GI) malignancies (gastric, gastroesophageal, and pancreatic cancer) undergoing neoadjuvant therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2015

Completed
6 days until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 12, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

February 28, 2018

Status Verified

February 1, 2018

Enrollment Period

1.6 years

First QC Date

November 25, 2015

Last Update Submit

February 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of Large-Scale Trial: Adherence & Contamination

    The mean adherence rates (percentage of prescribed sessions completed) in the intervention group will be determined based on weekly activity diaries. Activity diaries will be completed by the subject throughout their participation in the study and collected upon the end of participation. The mean contamination rates (completed exercise sessions) in the control group will also be determined based on weekly activity diaries.

    Throughout the course of neoadjuvant therapy (on average 10-12 weeks)

Secondary Outcomes (4)

  • Feasibility of a Large-Scale Trial: Eligibility & Willingness to Participate

    Completion of neoadjuvant therapy (on average 10-12 weeks)

  • Exercise Partner Benefits

    Completion of neoadjuvant therapy (on average 10-12 weeks)

  • Change in grip strength and upper body strength as a result of intervention

    Enrollment in study and completion of neoadjuvant therapy (on average 10-12 weeks)

  • Assessing the interaction between frailty and the Band Together program

    Completion of neoadjuvant therapy (on average 10-12 weeks)

Study Arms (2)

Exercise Education

ACTIVE COMPARATOR

Distribution of exercise education materials

Other: Exercise Education

Band Together

EXPERIMENTAL

A strength-training and walking program with or without an exercise partner throughout neoadjuvant therapy.

Behavioral: Band Together

Interventions

Band TogetherBEHAVIORAL

Band Together is a strength training program utilizing resistance bands with progressively increasing resistance, ranging from 3 to 35 pounds. Sessions are to be completed 3 times a week and involve 3 sets of 6 exercises: 1. chair stands, 2. chest press, 3. shoulder press, 4. arm curls, 5. pulls, and 6. calf raises. In addition, Band Together participants will be asked to work up to a walking goal of 10,000 additional steps per week.

Also known as: strength training and walking program
Band Together

Education will consist of counseling by the healthcare provider with supplemental handouts from the American College of Sports Medicine and the National Institute on Aging/ National Institutes of Health.

Exercise Education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • New diagnosis of potentially resectable or borderline resectable pancreatic adenocarcinoma, gastric adenocarcinoma, or adenocarcinoma of the gastroesophageal junction.
  • Patients must be evaluated at the Penn State Hershey Medical Center prior to receiving neoadjuvant chemotherapy or chemoradiation.
  • Patients must be deemed appropriate for neoadjuvant therapy by their treating health care providers.
  • The ability to speak and read English.
  • The ability to provide informed consent.

You may not qualify if:

  • Angina (stable or unstable)
  • Paraplegia or quadriplegia
  • Joint or muscle conditions that prevent the patient from being able to grip and or lift resistance bands.
  • Patients who have already started neoadjuvant chemotherapy at other institutions.
  • Presence of metastatic disease.
  • Gastric or pancreatic histologies other than adenocarcinoma.
  • Pregnant women.
  • Prisoners
  • Patients screening positive on the Physical Activity Readiness Questionnaire (PAR-Q)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

Related Publications (4)

  • Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol. 2015 Jul;22(7):2416-23. doi: 10.1245/s10434-014-4285-2. Epub 2014 Dec 18.

    PMID: 25519927BACKGROUND
  • Dale W, Hemmerich J, Kamm A, Posner MC, Matthews JB, Rothman R, Palakodeti A, Roggin KK. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014 May;259(5):960-5. doi: 10.1097/SLA.0000000000000226.

    PMID: 24096757BACKGROUND
  • van de Rest O, van der Zwaluw NL, Tieland M, Adam JJ, Hiddink GJ, van Loon LJ, de Groot LC. Effect of resistance-type exercise training with or without protein supplementation on cognitive functioning in frail and pre-frail elderly: secondary analysis of a randomized, double-blind, placebo-controlled trial. Mech Ageing Dev. 2014 Mar-Apr;136-137:85-93. doi: 10.1016/j.mad.2013.12.005. Epub 2013 Dec 27.

    PMID: 24374288BACKGROUND
  • Bollwein J, Diekmann R, Kaiser MJ, Bauer JM, Uter W, Sieber CC, Volkert D. Dietary quality is related to frailty in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):483-9. doi: 10.1093/gerona/gls204. Epub 2012 Oct 12.

    PMID: 23064817BACKGROUND

MeSH Terms

Interventions

Resistance Training

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Amanda B Cooper, MD

    Penn State College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician

Study Record Dates

First Submitted

November 25, 2015

First Posted

February 12, 2016

Study Start

December 1, 2015

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

February 28, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations